338 related articles for article (PubMed ID: 12552444)
41. Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women.
Grinsztejn B; Veloso VG; Levi JE; Velasque L; Luz PM; Friedman RK; Andrade AC; Moreira RI; Russomano F; Pilotto JH; Bastos FI; Palefsky J
Int J Infect Dis; 2009 Jan; 13(1):72-80. PubMed ID: 18632296
[TBL] [Abstract][Full Text] [Related]
42. High prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.
Smits PH; Bakker R; Jong E; Mulder JW; Meenhorst PL; Kleter B; van Doorn LJ; Quint WG
J Clin Microbiol; 2005 Dec; 43(12):5936-9. PubMed ID: 16333078
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus antibody responses among patients with incident cervical carcinoma.
Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
J Med Virol; 1997 Aug; 52(4):436-40. PubMed ID: 9260694
[TBL] [Abstract][Full Text] [Related]
44. Infection with human papillomavirus and HIV among young women in Kampala, Uganda.
Banura C; Franceschi S; Doorn LJ; Arslan A; Wabwire-Mangen F; Mbidde EK; Quint W; Weiderpass E
J Infect Dis; 2008 Feb; 197(4):555-62. PubMed ID: 18237268
[TBL] [Abstract][Full Text] [Related]
45. Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosa.
Sobhani I; Walker F; Aparicio T; Abramowitz L; Henin D; Cremieux AC; Soule JC
Clin Cancer Res; 2002 Sep; 8(9):2862-9. PubMed ID: 12231528
[TBL] [Abstract][Full Text] [Related]
46. Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women.
Aho J; Hankins C; Tremblay C; Lang F; Forest P; Pourreaux K; Rouah F; Coutlée F;
J Infect Dis; 2003 Nov; 188(10):1517-27. PubMed ID: 14624377
[TBL] [Abstract][Full Text] [Related]
47. Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men.
Pierangeli A; Scagnolari C; Degener AM; Bucci M; Ciardi A; Riva E; Indinnimeo M; Mancini G; D'Ettorre G; Vullo V; Antonelli G
AIDS; 2008 Oct; 22(15):1929-35. PubMed ID: 18784456
[TBL] [Abstract][Full Text] [Related]
48. Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.
Clifford GM; Shin HR; Oh JK; Waterboer T; Ju YH; Vaccarella S; Quint W; Pawlita M; Franceschi S
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1874-9. PubMed ID: 17855708
[TBL] [Abstract][Full Text] [Related]
49. The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions.
Marais DJ; Vardas E; Ramjee G; Allan B; Kay P; Rose RC; Williamson AL
J Infect Dis; 2000 Oct; 182(4):1239-42. PubMed ID: 10979925
[TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus, human immunodeficiency virus, and cervical cancer: newly recognized associations?
Vernon SD; Icenogle JP; Johnson PR; Reeves WC
Infect Agents Dis; 1992 Dec; 1(6):319-24. PubMed ID: 1344670
[TBL] [Abstract][Full Text] [Related]
51. The impact of the human immunodeficiency virus on the human papillomavirus epidemic.
Chopra KF; Tyring SK
Arch Dermatol; 1997 May; 133(5):629-33. PubMed ID: 9158417
[TBL] [Abstract][Full Text] [Related]
52. Evidence for the association of human papillomavirus infection and cutaneous squamous cell carcinoma in immunocompetent individuals.
Masini C; Fuchs PG; Gabrielli F; Stark S; Sera F; Ploner M; Melchi CF; Primavera G; Pirchio G; Picconi O; Petasecca P; Cattaruzza MS; Pfister HJ; Abeni D
Arch Dermatol; 2003 Jul; 139(7):890-4. PubMed ID: 12873884
[TBL] [Abstract][Full Text] [Related]
53. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.
Marais DJ; Passmore JA; Denny L; Sampson C; Allan BR; Williamson AL
J Med Virol; 2008 Jun; 80(6):953-9. PubMed ID: 18428143
[TBL] [Abstract][Full Text] [Related]
54. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus.
Kreimer AR; Alberg AJ; Daniel R; Gravitt PE; Viscidi R; Garrett ES; Shah KV; Gillison ML
J Infect Dis; 2004 Feb; 189(4):686-98. PubMed ID: 14767823
[TBL] [Abstract][Full Text] [Related]
55. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Ahdieh-Grant L; Li R; Levine AM; Massad LS; Strickler HD; Minkoff H; Moxley M; Palefsky J; Sacks H; Burk RD; Gange SJ
J Natl Cancer Inst; 2004 Jul; 96(14):1070-6. PubMed ID: 15265968
[TBL] [Abstract][Full Text] [Related]
56. Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected women.
Minkoff H; Shen X; Watts DH; Leighty R; Hershow R; Palefsky J; Tuomala R; Neu N; Zorrilla CD; Paul M; Strickler H
Obstet Gynecol; 2006 Oct; 108(4):953-60. PubMed ID: 17012459
[TBL] [Abstract][Full Text] [Related]
57. Effect of HIV infection on atypical squamous cells of undetermined significance.
Duerr A; Paramsothy P; Jamieson DJ; Heilig CM; Klein RS; Cu-Uvin S; Schuman P; Anderson JR;
Clin Infect Dis; 2006 Mar; 42(6):855-61. PubMed ID: 16477565
[TBL] [Abstract][Full Text] [Related]
58. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.
Carter JJ; Koutsky LA; Hughes JP; Lee SK; Kuypers J; Kiviat N; Galloway DA
J Infect Dis; 2000 Jun; 181(6):1911-9. PubMed ID: 10837170
[TBL] [Abstract][Full Text] [Related]
59. HIV-positive women and their care.
Squires K
Posit Aware; 1996; 7(1):13-4. PubMed ID: 11363116
[TBL] [Abstract][Full Text] [Related]
60. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women.
Durante AJ; Williams AB; Da Costa M; Darragh TM; Khoshnood K; Palefsky JM
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):638-42. PubMed ID: 12869403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
